---
figid: PMC11117114__etm-28-01-12565-g04
pmcid: PMC11117114
image_filename: PMC11117114__etm-28-01-12565-g04.jpg
figure_link: /pmc/articles/PMC11117114/figure/F5/
number: Figure 5
figure_title: Vitamin D3 mediates the TXNIP/NLRP3 inflammatory pathway by inhibiting
  oxidative stress.
caption: Vitamin D3 mediates the TXNIP/NLRP3 inflammatory pathway by inhibiting oxidative
  stress. Expression of (A) NLRP3, (B) TXNIP, (C) α-SMA, (D) E-cadherin and (E) Bax/Bcl2
  in cells detected by reverse transcription-quantitative PCR and (F) western blotting.
  Protein expression of (G) NLRP3, (H) TXNIP, (I) α-SMA, (J) E-cadherin and (K) Bax/Bcl2.
  n=4. *P<0.05, **P<0.01, ***P<0.001. TXNIP, thioredoxin interacting protein; VD3,
  vitamin D3; 8-OHDG, 8-hydroxy-2'-deoxyguanosine; α-SMA, α-smooth muscle actin; STZ,
  streptozotocin; HG, high glucose; NAC, N-acetyl-L-cysteine
article_title: 'Therapeutic potential of vitamin D3 in mitigating high glucose‑induced
  renal damage: Mechanistic insights into oxidative stress inhibition and TXNIP/NLRP3
  signaling pathway blockade'
citation: Guanqing Li, et al. Exp Ther Med. 2024 Jul;28(1).
year: '2024'
pub_date: 2024-7-
epub_date: 2024-5-09
doi: 10.3892/etm.2024.12565
journal_title: Experimental and Therapeutic Medicine
journa_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos
keywords:
- diabetic nephropathy
- oxidative stress
---
